Oximio Türkiye Expands Cold Chain Capacity
We’re excited to share that Oximio Türkiye has recently completed the installation of a new 2–8°C cold room, which will become operational by the end of the year.
This investment increases our cold storage and handling capacity by more than 50%, ensuring we can continue to meet the needs of our growing operational activities and better support our clinical research partners.
Our new cold storage facility is fully compliant with Oximio standards and is designed to maintain the highest quality and integrity for a wide range of products, including:
- Antibiotics
- Biological Goods
- Blood Products or Derivatives
- Controlled Drugs (on request)
- Cytotoxic Materials
- Dangerous Goods
- Genetically Modified Organisms
- Radioactive Materials (on request)
- Ancillary Supplies/Equipment
At Oximio, we remain committed to advancing our infrastructure to provide reliable, compliant, and scalable logistics solutions for clinical research across the region.
Find out more about how Oximio Türkiye can support your next clinical trial: https://oximio.com/network/turkiye/
